Martin Pfaffendorf
Overview
Explore the profile of Martin Pfaffendorf including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
72
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Balt J, Mathy M, Pfaffendorf M, Van Zwieten P
J Hypertens Suppl
. 2002 Aug;
20(5):S3-11.
PMID: 12184061
It is well known that angiotensin II (Ang II) can facilitate the effects of sympathetic neurotransmission. In the present study, using various experimental models, we investigated the inhibitory effects of...
22.
Peters S, Sand C, Michel M, Pfaffendorf M, Van Zwieten P
Naunyn Schmiedebergs Arch Pharmacol
. 2002 Jul;
366(2):189-91.
PMID: 12122507
The activation of mitogen-activated protein kinase (MAPK) pathways in the heart, for instance by alpha(1)-adrenoceptor agonists and endothelin-1, has primarily been associated with cellular growth regulation. Here we have investigated...
23.
Balt J, Mathy M, Nap A, Pfaffendorf M, Van Zwieten P
J Cardiovasc Pharmacol
. 2002 Jun;
40(1):50-7.
PMID: 12072577
Effects of angiotensin II type 1 (AT1) receptor antagonists eprosartan and candesartan and AT2 receptor antagonist PD123319 on Ang II-induced facilitation of noradrenergic neurotransmission were investigated in isolated rabbit mesenteric...
24.
Streefkerk J, Mathy M, Pfaffendorf M, Van Zwieten P
J Hypertens
. 2002 May;
20(6):1175-80.
PMID: 12023688
Objective: Several studies have shown that arginine vasopressin (AVP) potentiates the sympathetic nervous transmission in isolated vessels. The present study investigates such a potentiation in the pithed rat model. Methods:...